Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
ARWR · against 175 other Healthcare companies of similar size
Ranked #160 of 176 · scores higher than 9% of peers · safety percentile 10
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)24 peers with a safety percentile of 10–19, including ARWR · Click a bar to see the companies
Mainly because of its debt / equity and beta, which are weaker than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | ARWR | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 170 reported | 2.96× | 0.33× | 6% | 33% | |
| BetaLower is better · 177 reported | 1.30 | 0.58 | 13% | 33% | |
| Current ratioHigher is better · 167 reported | 5.90× | 2.49× | 81% | 33% |
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 5.6B USD | 100 | 53 | |
| 1 | 6.6B USD | 100 | 45 | |
| 3 | 10.1B EUR (≈$11.1B) | 99 | ||
| 4 | 9.0B USD | 98 | 51 | |
| 5 | 4.6B USD | 98 | 29 | |
| 156 | 26.0B BRL (≈$4.7B) | 12 | 60 | |
| 157 | 13.8B USD | 12 | 54 | |
| 158 | 5.7B USD | 11 | 38 | |
| 159 | 77.1B DKK (≈$11.6B) | 11 | 47 | |
| 160 | 8.4B USD | 10 | 28 | |
| 161 | 68.0B BRL (≈$12.2B) | 10 | 67 | |
| 162 | 5.7B USD | 10 | 30 | |
| 163 | 12.7B AUD (≈$8.4B) | 10 | 38 | |
| 164 | 4.7B USD | 9 | 42 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score